Skip to content

Postdural Puncture Headache After Spinal Anesthesia for Cesarean Section

The Effect of Glass Particle Contamination From Bupivacaine Ampules on Postdural Puncture Headache After Spinal Anesthesia for Cesarean Section: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06683807
Enrollment
55
Registered
2024-11-12
Start date
2024-12-31
Completion date
2025-12-31
Last updated
2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache

Brief summary

Post-dural puncture headache (PDPH) is a potential and debilitating complication of spinal anesthesia in pregnant patients undergoing caesarean sections (CS), with a reported incidence of 0.5%-2% .

Detailed description

Various methods for the management of PDPH are present including proper hydration, maintaining a supine posture, caffeine, paracetamol, nonsteroid anti-inflammatory drugs (NSAID), theophylline, opioids like morphine and fentanyl, with the only clearly effective treatment being the epidural blood patch. Glass particle contamination is known to occur on opening single-dose drug ampoules. Although supporting data are lacking, intrathecal drug administration during subarachnoid blocks and chemotherapy with glass particle contamination is potentially hazardous,

Interventions

DRUGHyperbaric bupivacaine 0.5% (2.5 mL) aspirated immediately after opening the bupivacaine ampule

Parturients will receive spinal anesthesia for elective cesarean delivery with injection of 25 μg fentanyl plus 12.5 mg of hyperbaric bupivacaine 0.5% (2.5 mL) immediately after opening the bupivacaine ampule and directly after immediate aspiration with an unfiltered 3 ml syringe

DRUGHyperbaric bupivacaine 0.5% (2.5 mL) aspirated 5 minutes delayed after opening the bupivacaine ampule

Parturients will receive spinal anesthesia for elective cesarean delivery with injection of 25 μg fentanyl plus 12.5 mg of hyperbaric bupivacaine 0.5% (2.5 mL) directly after 5 min' delayed aspiration from opening of the bupivacaine ampule with an unfiltered 3 ml syringe to allow glass particles to settle onto the bottom of the ampule

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Parturient with American Society of Anesthesiologists (ASA) class I or II * Age: 20-45 years old * A full-term pregnant female undergoing elective cesarean section under spinal anesthesia

Exclusion criteria

* Contraindications to regional anesthesia (coagulopathy, infection at the needle insertion site) * History of Migraines or persistent headache * Known hypersensitivity to local anesthetics * Body mass index (BMI \> 35 kg/m2) * Hypertensive disorders of pregnancy * Emergency cesarean section * Cardiorespiratory, hepatic, or renal impairment * History of a cerebrovascular accident, neurologic or psychological disorders * Uncontrolled hypertension * Spinal column surgery, chronic opioid consumption * Patients with more than one single attempt and patients with blood loss over 1000 mL who will need additional fluid supplementation or blood transfusion * Patient refusal

Design outcomes

Primary

MeasureTime frameDescription
The incidence of post-dural puncture headache (PDPH)The first 120 hours during the post-partum period.Assessed using the visual analog score of pain which ranges from 0-10, where 0 = no pain and 10 = maximum worst pain

Contacts

Primary ContactSeham M Moeen, MD
seham.moeen@aun.edu.eg01006386324
Backup ContactEsraa A Abdelsamad
Esraa.16266100@med.aun.edu.eg01024587718

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026